Extensive cerebrospinal fluid enhancement following gadolinium chelate administration: Possible pathogenesis

Acta Radiologica

Volumn 46, Issue 5, 2005, Pages 523-527

  Hsu, H L ^a,b   Chen, C J ^a,b  

^a E DA HOSPITAL   (Taiwan)

^b I SHOU UNIVERSITY   (Taiwan)

Author keywords

Blood brain barrier; Gadolinium; Leptomeningeal enhancement; Magnetic resonance images

Indexed keywords

COMPUTERIZED TOMOGRAPHY; FLUID MECHANICS; GADOLINIUM; MAGNETIC RESONANCE IMAGING; PATHOLOGY;

BLOOD-BRAIN CARRIER; LEPTOMENENGIAL ENHANCEMENT; MAGNETIC RESONANCE IMAGES;

BIOMEDICAL ENGINEERING;

CONTRAST MEDIUM; GADOLINIUM PENTETATE;

ARTICLE; ARTIFACT; BLOOD BRAIN BARRIER; BRAIN; CASE REPORT; CEREBROSPINAL FLUID; CONTRAST MEDIUM EXTRAVASATION; HUMAN; IMAGE ENHANCEMENT; MALE; METABOLISM; METHODOLOGY; MIDDLE AGED; NUCLEAR MAGNETIC RESONANCE IMAGING; OLIGODENDROGLIOMA; PATHOLOGY; PRESCHOOL CHILD;

ARTIFACTS; BLOOD-BRAIN BARRIER; BRAIN; CHILD, PRESCHOOL; CONTRAST MEDIA; EXTRAVASATION OF DIAGNOSTIC AND THERAPEUTIC MATERIALS; GADOLINIUM DTPA; HUMANS; IMAGE ENHANCEMENT; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OLIGODENDROGLIOMA;

EID: 27744519919     PISSN: 02841851     EISSN: 16000455     Source Type: Journal    
DOI: 10.1080/02841850510021472     Document Type: Article

References (18)

1. Bazzao A, Floris R, Fasoli F, Fantozzi LM, Colonnese C, Simonetti G. Cerebrospinal fluid changes after intravenous injection of gadolinium chelate: assessment by FLAIR imaging. Eur Radiol 2003; 13:592-7.
2. Berger B, Ortiz O, Gold A, Hilal SK. Total cerebrospinal fluid enhancement following intravenous Gd-DTPA administration in a case of meningiomatosis. Am J Neuroradiol 1992;13:15-18.
3. Dechambre SD, Duprez T, Grandin CB, Lecouvet FE, Peeters A, Cosnard G. High signal in cerebrospinal fluid mimicking subarachnoid hemorrhage on FLAIR following acute stroke and intraveneous contrast medium. Neuroradiology 2000;42:608-11.
4. DeWispelaere JF, Trigaux JP, VanBeers B, Gilliard C. Cortical and CSF hyperdensity after iodinated contrast medium overdose: CT findings. J Comput Assist Tomogr 1992; 16:998-9.
5. Eckel TS, Breiter SN, Monsein LH. Subarachnoid contrast enhancement after spinal angiography mimicking diffuse subarachnoid hemorrhage. Am J Roentgenol 1998;170:503-5.
6. Frank JA, Girton M, Dwyer AJ, Wright DC, Cohen PJ, Doppman JL. Meningeal carcinomatois in the VX2 rabbit tumor model: detection with Gd-DTPA-enhanced MR imaging. Radiology 1988;167:825-9.
7. Knutzon RK, Poirier VC, Gerscovich EO, Brock JM, Buonocore M. The effect of intravenous gadolinium on the magnetic resonance appearance of cerebrospinal fluid. Invest Radiol 1991;26:671-3.
8. Mamourian AC, Hoopes PJ, Lewis LD. Visualization of intravenously administered contrast material in the CSF on fluid-attenuated inversion-recovery MR images: an in vitro and animal-model investigation. Am J Neuroradiol 2000;21:105-11.
9. Naul LG, Finkenstaedt M. Extensive cerebrospinal fluid enhancement with gadopentetate dimeglumine in a primitive neuroectodermal tumor. Am J Neuroradiol 1997;18:1709-11.
10. Numaguchi Y, Fleming MS, Hasuo K, Puyau FA, Nice CMJ. Blood-brain barrier disruption due to cerebral angiography: CT findings. J Comput Assist Tomogr 1984;8:936-9.
11. Pui MHW, Langston JW, Arai Y. Gd-DTPA enhancement of CSF in meningeal carcinomatosis. J Comput Assist Tomogr 1993;17:940-4.
12. Rai AT, Hogg JP. Persistence of gadolinium in CSF: a diagnostic pitfall in patients with end-stage renal disease. Am J Neuroradiol 2001;22:1357-61.
13. Rapoport SI, Thompson HK, Bindinger JM. Equiosmolal opening of the blood-brain barrier in the rabbit by different contrast media. Acta Radiol Diagn 1974;15:21-32.
14. Sage MR. Blood-brain barrier: phenomenon of increasing importance to the imaging clinician. Am J Roentgenol 1982;138:887-98.
15. Sage MR, Wilson AJ, Scroop R. Contrast media and the brain. The basis of CT and MR imaging enhancement. Neuroimaging Clin N Am 1998;8:695-707.
16. Sakamoto S, Kitagaki H, Ishii K, Yamaji S, Ikejiri Y, Mori E. Gadolinium enhancement of the cerebrospinal fluid in a patient with meningeal fibrosis and cryptococcal infection. Neuroradiology 1997;39:504-5.
17. Schuhmann-Giampieri G, Krestin G. Pharmacokinetics of Gd-DTPA in patients with chronic renal failure. Invest Radiol 1991;26:975-9.
18. Sharp S, Stone J, Beach R. Contrast agent neurotoxicity presenting as subarachnoid hemorrhage. Neurology 1999;52:1503-5.